Private health sector faces licensing delays, import dependence, API challenges
Business leaders have called for public-private partnerships, rational drug pricing, developing the API sector and an easier licensing process.
Business leaders have called for public-private partnerships, rational drug pricing, developing the API sector and an easier licensing process.